Alejandro R. Cravioto
C.p. 04510
Coyoacan, DIF 04510, Mexico
Coyoacan, DIF 04510, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Comparative Genomics of Escherichia coli Serogroups 64474, O179, O188 and Shigella boydii O16.
Journal: Pathogens (Basel, Switzerland)
Published: March 28, 2026
Expression of the VapD protein by Helicobacter pylori during intracellular infection.
Journal: Microbiology (Reading, England)
Published: March 23, 2026
vapD Mutation Shows Impairment in the Persistence of Helicobacter pylori Within AGS Cells.
Journal: Microorganisms
Published: July 04, 2025
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.
Journal: Vaccines
Published: September 03, 2024
The role of the Pan American Committee for Safe Vaccination (COPAVASE) in strengthening safe vaccination in the AmericasO papel do Comitê Pan-Americano de Vacinação Segura (COPAVASE) no fortalecimento da vacinação segura nas Américas
Journal: Revista panamericana de salud publica = Pan American journal of public health
Published: May 20, 2024
Pseudomonas aeruginosa strains isolated from animal with high virulence genes content and highly sensitive to antimicrobials.
Journal: Journal of global antimicrobial resistance
Published: June 19, 2023
Who to vaccinate first? A peek at decision-making in a pandemic.
Journal: Nature
Published: July 13, 2022
Two Years of Evolutionary Dynamics of SARS-CoV-2 in Mexico, With Emphasis on the Variants of Concern.
Journal: Frontiers in microbiology
Published: February 28, 2022
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
Journal: The Lancet. Infectious diseases
Published: January 11, 2022
COVID-19 impact on infant and adolescent vaccine supplies.
Journal: Science (New York, N.Y.)
Published: December 16, 2021
COVID-19 vaccine strategies must focus on severe disease and global equity.
Journal: Lancet (London, England)
Published: November 24, 2021
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Journal: Vaccine
Published: October 18, 2021
Last Updated: 09/26/2026